<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04099225</url>
  </required_header>
  <id_info>
    <org_study_id>MBW-normal values</org_study_id>
    <nct_id>NCT04099225</nct_id>
  </id_info>
  <brief_title>Multiple Breath Washout (MBW) Using Sulfur Hexafluoride Reference Values and Influence of Anthropometric Parameters</brief_title>
  <official_title>Multiple Breath Washout (MBW) Using Sulfur Hexafluoride Reference Values and Influence of Anthropometric Parameters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsmedizin Mannheim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsmedizin Mannheim</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multiple breath washout (MBW) using Sulphur hexafluoride (SF6) has the potential to reveal
      ventilation heterogeneity in obstructive lung disease which is frequent in patients with
      small airway disease. However, it is missed by commonly used tests with reference data being
      scarce and mostly restricted to younger collectives. We aimed to evaluate the influence of
      anthropometric parameters on SF6-MBW reference values in pulmonary healthy adults.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2015</start_date>
  <completion_date type="Actual">May 2019</completion_date>
  <primary_completion_date type="Actual">May 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Lung clearance index (LCI) derived from multiple breath washout testing (MBW)</measure>
    <time_frame>30 minutes</time_frame>
    <description>global ventilation heterogeneity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acinar phase-III-slope (Sacin) derived from multiple breath washout testing (MBW)</measure>
    <time_frame>30 minutes</time_frame>
    <description>local ventilation heterogeneity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Conductive phase-III-slope (Scond) derived from multiple breath washout testing (MBW)</measure>
    <time_frame>30 minutes</time_frame>
    <description>local ventilation heterogeneity</description>
  </secondary_outcome>
  <enrollment type="Actual">104</enrollment>
  <condition>Healthy Subjects</condition>
  <condition>Smokers</condition>
  <condition>Non-smokers</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Multiple breath washout (MBW) testing</intervention_name>
    <description>Lung clearance index (LCI), acinar (Sacin) and conductive (Scond) ventilation heterogeneity were derived from triplicate SF6-MBW measurements. Global ventilation heterogeneity was calculated for the 2.5% (LCI2.5) and 5% (LCI5) stopping points.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        healthy volunteers including never, active and former smokers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        non-smoker

          -  no history of pulmonary disease

          -  absence of dyspnoea, cough, thoracic pain

          -  no self-reported smoking history

          -  normal lung function testing

               -  normal shape of flow-volume curve

               -  normal shape of flow-pressure curve

               -  FEV1/FVC &gt;70% (forced expiratory volume in 1 second / forced vital capacity)

               -  TLC &gt; 80% of predicted (total lung capacity)

               -  TLCO/VA &gt; 80% of predicted (transfer factor corrected for ventilated alveolar
                  volume)

               -  R5 &lt; 150% of predicted (resistance at 5Hz, impulse oscillometry)

        smoker

        - as above, but with self-reported smoking history &gt;10 pack years

        Exclusion Criteria:

          -  unwilling or unable to give informed consent

          -  history of any respiratory disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frederik Trinkmann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Mannheim</affiliation>
  </overall_official>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 18, 2019</study_first_submitted>
  <study_first_submitted_qc>September 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 23, 2019</study_first_posted>
  <last_update_submitted>September 19, 2019</last_update_submitted>
  <last_update_submitted_qc>September 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsmedizin Mannheim</investigator_affiliation>
    <investigator_full_name>Dr. Frederik Trinkmann</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Sharing of individual participant data is prohibited by data protection regulations. Summarized data including the models will be made available thru an online repository (GitHub).</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

